mRNA expression of MDR1 and major metabolising enzymes in human fetal tissues

Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 6, 2009, Pages 529-536

  Fakhoury, May ^a   de Beaumais, Tiphaine ^a   Guimiot, Fabien ^a   Azougagh, Said ^a   Elie, Valery ^a   Medard, Yves ^a   Delezoide, Anne Lise ^a   Jacqz Aigrain, Evelyne ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Foetus; Metabolising enzymes; mRNA expression; Tissue distribution; Transporters

Indexed keywords

CARRIER PROTEIN; DRUG METABOLIZING ENZYME; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DUODENUM; ENZYME ACTIVITY; FETUS; FETUS (ANATOMY); GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC VARIABILITY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; KIDNEY; LIVER;

EID: 73349093447     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.24.529     Document Type: Article

References (17)

1. Nishimura, M. and Naito, S.: Tissue specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug. Metab. Pharmmacokinet., 20: 452-477 (2005).
2. Nishimura, M., Naito, S. and Yokoi, T.: Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug. Metab. Pharmacokinet., 19: 135-149 (2004).
3. Van Kalken, G. K., Giaccone, G., van der Valk, P., Kuiper, C. M., Hadisaputro, M. M. N., Bosma, S. A. A., Scheper, R. J., Meijer, C. J. L. M. and Pinedo, H. M.: Multridrug resistance gene (P-gp) expression in the human fetus. Am. J. Pathol., 141: 1063-1072 (1992).
4. Nishimura, M., Yaguti, H., Yoshitsugu, H., Naito, S. and Satoh, T.: Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku. Zasshi., 123: 369-375 (2003).
5. Lacroix, D., Sonnier, M., Moncion, A., Cheron, G. and Cresteil, T.: Expression of CYP3A in the human liver. Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur. J. Biochem., 247: 625-634 (1997).
6. Hines, R. N. and Mccarver, D. G.: The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J. Pharmacol. Exp. Ther., 300: 355-360 (2002).
7. de Wildt, S. N., Kearns, G. L., Leeder, J.S. and van den Anker, J.N.: Cytochrome P4503A. Otogeny and drug disposition. Clin. Pharmacokinet., 37: 485-505 (1999).
8. Nishimura, M. and Naito, S.: Tissue specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug. Metab. Pharmacokinet., 21: 357-374 (2006).
9. Stewart, M. J., Malek, K. and Crabb, D. W.: Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. J. Investig. Med., 44: 42-46 (1996).
10. Schwer, H., Langmann, T., Daig, R., Becker, A., Aslanidis, C. and Schmitz, G.: Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun., 233: 117-120 (1997).
11. Coller, J. K., Fritz, P., Zanger, U. M., Siegle, I., Eichelbaum, M., Kroemer, H. K. and Murdter, T. E.: Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours. Histochem. J., 33: 329-336 (2001).
12. Jaiswal, A. K.: Human NAD(P)H: quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression. J. Biol. Chem., 269: 14502-14508 (1994).
13. Nishimura, M. and Naito, S.: Tissue specific mRNA expression profiles of human carbohydrate sulfotransferase and tyrosylprotein sulfotransferase. Biol. Pharm. Bull., 30: 821-825 (2007).
14. Tunbridge, E. M., Lane, T. A. and Harrison, P. J.: Expression of multiple catechol-o-methyltransferase (COMT) mRNA variants in human brain. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 144: 834-839 (2007).
15. Windmill, K. F., Gaedigk, A., Hall, P. M., Samaratunga, H., Grant, D. M. and McManus, M. E.: Localization of N-Acetyltransferases NAT1 and NAT2 in Human Tissues. Toxicol. Sci., 54: 19-29 (2000).
16. Gaughan, D. J., Barbaux, S., Kluijtmans, L. A. and Whitehead, A. S.: The human and mouse methylenetetrahydrofolate reductase (MTHFR) genes: genomic organization, mRNA structure and linkage to the CLCN6 gene. Gene., 257: 279-289 (2000).
17. Hines, R. N.: The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther., 118: 250-267 (2008).